Inventia Life Science Announces Third Dimension Grant for 3D Cell Culture Research
View
Inventia continues global expansion into the Indian market through a distribution agreement for RASTRUM™ with Biotron Healthcare PVT Ltd
View
Inventia Life Science collaborates with MSD to develop 3D advanced cell models for neurodegenerative disease drug discovery
View
Inventia enters into a distribution agreement for RASTRUM™ with SCRUM Inc in Japan
View
Inventia Life Science secures NSW Government Jobs Plus support to build a brand-new manufacturing and R&D facility in Sydney
View
Inventia Life Science cements its US presence by opening its first US office and facility at The Innovation Space™ in Wilmington, Delaware
View
Inventia has been named on the 2022 AFR BOSS Most Innovative Companies List
View
Healthcare super fund HESTA directly invests in Inventia Life Science
View
Clamping down on the causes of pre-eclampsia
View
Inventia Life Science Accelerates Growth with AU$35 million Series B
View
Australian company accelerating the speed of drug discovery wins prestigious Eureka prize
View
Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discovery
View
Inventia Life Science and BioLamina partner to advance cell matrices for complex 3D cell models
View
Inventia Life Science Announces Partnership with PhenoVista Biosciences to Accelerate Preclinical Research with 3D Cell Models
View
RASTRUM™ - the 3D Printer of Living Cells, Honored in Annual Awards by Leading Business Magazine
View
How a Sydney 3D printing start-up is revving up cancer research | Westpac
View
Inventia wins Australia’s Good Design Award of the Year for RASTRUM 3D bioprinter | 3D Printing Media Network
View
Good Design Awards prove the power of creativity in every sphere | Australian Financial Review
View
What It Takes to Design a Bioprinter for Cancer Research, from Inventia Life Sciences | 3DPrint.com
View
E140 – Dr Julio Ribeiro, Inventia Life Science | Open the Pod Bay Doors | Podcast
View